Mark A Jones

The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan

T. Graves, J. Marsh, J. Totterdell, 2020, Trials.

SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia

S. Tong, J. Carapetis, R. Walker, 2019, BMJ Open.

ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

V. Jha, A. Bowen, Z. McQuilten, 2022, Trials.

Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule

M. Estcourt, J. Marsh, P. Richmond, 2022, Trials.

Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial

J. Carapetis, A. Leach, L. Kirkham, 2022, The Journal of infectious diseases.

Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis

C. Blyth, R. Gibbs, T. Snelling, 2020, Journal of epidemiology.

The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

J. Carapetis, A. Leach, J. Marsh, 2019, BMJ Open.